Pharmaceutical Related Topics 
Fierce Pharma
MARCH 28, 2024
[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides
European Pharmaceutical Review
APRIL 18, 2024
What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). A well-designed wastewater sampling plan will ensure that representative samples are collected.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
APRIL 22, 2024
Discover the groundbreaking patent granted to Recursion Pharmaceuticals Inc for compounds Formula (I) and (II) to treat diseases. Learn about the innovative pharmaceutical compositions and treatment methods.
Fierce Pharma
SEPTEMBER 20, 2023
ARS Pharmaceuticals learned that lesson the hard way, as the FDA issued a surprise rejection of its anaphylaxis nasal spray Neffy. Positive FDA advisory committee votes aren’t always a blueprint for approval. Positive FDA advisory committee votes aren’t always a blueprint for approval.
Fierce Pharma
AUGUST 31, 2023
In this interview, Bruce Cozadd, Chairman and CEO of Jazz Pharmaceuticals, discusses Jazz’s 20-year legacy and what it means to create an organization that is both patient-focused and a great place | Jazz Pharmaceuticals’ Chairman and CEO discusses the company’s longstanding history of bringing new medicines to patients with limited or no options.
European Pharmaceutical Review
JANUARY 9, 2024
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. AI and future perspectives: a glimpse into tomorrow Figure 2: adapted from Saha, G.
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. In summary, considering the serious diseases caused by contaminated pharmaceuticals and the challenges discussed, Ahmed et al.
Expert insights. Personalized for you.
147 
Let's personalize your content